Leaflet CUTAQUIG 165mg / ml subcutaneous injection solution

Indicated for: immunosuppression

Route of administration: subcutaneous / cutaneous

Substance: normal human immunoglobulin (immunoglobulin)

ATC: J06BA01 (Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Normal human immunoglobulin is used for the treatment and prevention of infections in patients with primary or secondary immune deficiencies. It contains antibodies that help strengthen the immune system.

The medication is administered intravenously, as directed by a doctor. The dose and frequency of administration are adjusted based on the patient's condition.

Side effects may include headache, fever, nausea, or injection site reactions. In rare cases, severe allergic reactions or thrombosis may occur.

Normal human immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about CUTAQUIG 165mg / ml

  • Substance: normal human immunoglobulin
  • Date of latest medicines list: 01-06-2026
  • Product code: W66182003
  • Concentration: 165mg / ml
  • Pharmaceutical form: subcutaneous injection solution
  • Quantity: 1
  • Product type: Original
  • Price: 839.04 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M.B.H. - AUSTRIA
  • Holder: OCTAPHARMA (IP) SPRL - BELGIA
  • Number: 12086/2019/05
  • Shelf life: 24 months

Pharmaceutical forms available for normal human immunoglobulin

Concentrations available for normal human immunoglobulin

  • 100g/l
  • 100mg/ml
  • 165mg/ml
  • 200mg/ml

Other substances similar to normal human immunoglobulin

Compensation lists for CUTAQUIG 165mg / ml Octapharma

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

839.04 RON

839.04 RON

0.00 RON

NHP 6.15 (C2) - Primary immunodeficiency syndrome

Price

Copayment

Patient

839.04 RON

839.04 RON

0.00 RON

NHP 6.5.1 (C2) - Inflammatory-immune neurological diseases

Price

Copayment

Patient

839.04 RON

839.04 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

839.04 RON

839.04 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

839.04 RON

839.04 RON

0.00 RON